33095-94-2 Usage
General Description
1-(1,3-benzodioxol-5-yl)-1-isopropylurea, also known as 5-Allyl-1,3-benzodioxole-5-carboxamide, is a chemical compound with the molecular formula C11H13N3O3. It is a urea derivative and is classified as a drug and pesticide intermediate. 1-(1,3-benzodioxol-5-yl)-1-isopropylurea is believed to have potential as a central nervous system stimulant and has been researched for its potential use in the treatment of various neurological and psychiatric disorders. 1-(1,3-benzodioxol-5-yl)-1-isopropylurea is also used in the synthesis of various pharmaceuticals and agrochemicals due to its diverse chemical properties. However, further research and testing are needed to fully understand its potential applications and effects.
Check Digit Verification of cas no
The CAS Registry Mumber 33095-94-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,0,9 and 5 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 33095-94:
(7*3)+(6*3)+(5*0)+(4*9)+(3*5)+(2*9)+(1*4)=112
112 % 10 = 2
So 33095-94-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H14N2O3/c1-7(2)13(11(12)14)8-3-4-9-10(5-8)16-6-15-9/h3-5,7H,6H2,1-2H3,(H2,12,14)
33095-94-2Relevant articles and documents
Substituted quinazolines and analogs and use thereof
-
, (2008/06/13)
The invention relates to novel quinazolines and heterocycles which are antagonists or positive modulators of AMPA receptors, and the use thereof for treating, preventing or ameliorating neuronal loss associated with stroke, global and focal ischemia, CNS trauma, hypoglycemia and surgery, as well as treating or ameliorating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease and Down's syndrome, treating, preventing or ameliorating the adverse consequences of the overstimulation of the excitatory amino acids, treating, preventing or ameliorating anxiety, psychosis, convulsions, chronic pain, glaucoma, retinitis, urinary incontinence, muscular spasm and inducing anesthesia, as well as for treating or ameliorating the adverse consequences of excitatory amino acid deficiency such as schizophrenia, myoclonus. Alzheimer's disease and malnutrition and neural maldevelopment, and as cognition and learning enhancers.
1-Alkyl-4-aryl-3,4-dihydro-2(1H)-quinazolinones and thiones. Synthesis and 1H-NMR spectra
Houlihan,Cooke,Danzer,Nicoletti
, p. 1453 - 1456 (2007/10/02)
-